Intensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes
Figure 1
Overall survival of 60 patients with hypopharyngeal-laryngeal cancer.